Biden administration takes big step in making drugs affordable for patients: Also strengthens non-discrimination protections

“This is a huge win for patients. Insurers have made it almost impossible for patients to afford their medications by first requiring them to meet a high deductible and then charging high co-insurance, which is a percentage of the list price of the drug. By limiting patient copays and keeping more drugs outside of the deductible, patients will be better able to afford their medications. We only wish the Biden administration would have applied these principles to more metal levels and drug tiers, but this provides better options for people who rely on prescription drugs.”

Promoting PrEP and ensuring its coverage and affordability

HIV+Hep’s Carl Schmid spoke at the NMAC’s 2022 Biomedical HIV Prevention Summit on efforts to create a national program to increase the promotion of PrEP to those communities most in need & their providers, ways PrEP can be covered and made more affordable and accessible, implementation barriers and how to overcome them, and ideas on how to provide PrEP for the uninsured & underinsured.

Ending Hepatitis is something we can all do every day

“To end infectious diseases, we always need more scientific advances, but it is going to take a strategic, coordinated, & resourced public health response. Fortunately, we now have national strategic plans to end several infectious diseases including viral hepatitis, HIV, & STIs. A strength included in all the plans is a reliance on taking a syndemic approach to these often intersecting epidemics. Together we can get to the finish line faster.”

Biden Budget Boosts Domestic HIV Funding & Proposes Nationwide PrEP Delivery Program: CDC Hepatitis Program Receives Increase

President Biden is proposing an increase of $377 million for the Ending the HIV Epidemic in the U.S. initiative for a total of $850 million for efforts to end HIV by 2030. Additionally, in response to the HIV community and several members of Congress’ request to develop a program to increase access to PrEP, which are medications that prevent HIV, the president’s budget calls for the creation of an ambitious ten-year $9.8 billion nationwide PrEP delivery program. The budget includes numerous other program increases, including a bump of $13.5 million for the CDC’s hepatitis division.

Congressional Funding Slows for Ending HIV Initiative--Hepatitis Programs Left with a Minimal Increase

“In the omnibus appropriations bill released recently, Congress has significantly slowed the increase of funding for the Ending the HIV Epidemic in the U.S. initiative and put in jeopardy efforts to end HIV by 2030. Instead of supporting an increase of $245 million, as was proposed in President Biden’s budget and passed by the House and proposed by Senate Democratic leaders, the final bill allocates an increase of only $70 million for HIV testing, prevention, treatment, and research programs for those jurisdictions most impacted by HIV . . . . The funding level for hepatitis falls well short of the community’s request of $134 million for the CDC Hepatitis Division.”

Federal Government Issues Guidance to Insurers on Coverage of HIV Prevention Drugs

The federal government issued guidance to insurers to remind them of their obligation to cover pre-exposure prophylaxis (PrEP), which are drugs that prevent HIV, at no cost to their beneficiaries. The guidance, in the form of an FAQ, also clarifies that associated services with PrEP, such as provider visits and HIV, hepatitis, and STD testing along with other laboratory tests, must also be covered with no patient cost-sharing.

Who We Are

Monitors policies that impact the prevention and treatment of HIV, viral hepatitis, and other health conditions in the United States.

Communicates with members of the HIV, hepatitis, and other patient group communities on key policy issues that impact their access to healthcare.

Educates policymakers and members of the media about efforts to end both HIV and hepatitis in the United States and to improve access to quality and affordable healthcare for people with or at risk of serious or chronic health conditions.

Causes We Care About, and So Should You!


Promote necessary funding, programs, and policies to end the HIV epidemic in the United States


Promote necessary funding, programs, and policies to end viral hepatitis in the United States


Promote necessary funding, programs, and policies to end viral hepatitis in the United States

Facebook posts by @HIV+Hep

Tweets by @HIV+Hep

@HIVHep’s Carl Schmid, in testimony to the @councilofdc health comm.: “[We] strongly support the “Copay Accumulator Amendment Act of 2021,” [which] requires that the copay assistance beneficiaries receive counts toward their out-of-pocket obligations”: ( HIVHep photo
@HIVHep’s Carl Schmid in @statnews urging @AppropsDems @HouseAppropsGOP to fund a #PrEP nat’l grant prog: “The end of the #HIV epidemic, which began 40 years ago, is truly within sight. New $$ to promote/distribute PrEP is the next essential step”: HIVHep photo
@HIVHep’s Carl Schmid to @councilofdc’s Committee on Health: “For the benefit of DC residents who rely on #Rx to maintain their health, we urge you to pass [the “Copay Accumulator Amendment Act of 2021]”: HIVHep photo
Regarding House FY23 approps to #endHIV, @HIVHep’s Carl Schmid wrote: “While we are appreciative of the proposed ↑, we are disappointed that funding for a nat’l #PrEP access prog was not included,” prioritized by @POTUS & advanced by the #HIV community: HIVHep photo
82-year-old Patrick Leahy needs hip surgery after falling in his Virginia home. Unclear how long he’ll be out in the 50-50 Senate. Senators are on recess next week as well. His office notes he was “born blind in one eye” and “has had a lifelong struggle” with depth perception HIVHep photo

Pin It on Pinterest